심혈관 및 연조직 수복 패치 시장 보고서(2026년)
Cardiovascular And Soft Tissue Repair Patches Global Market Report 2026
상품코드 : 1942527
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,727,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,723,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,720,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

심혈관 및 연조직 수복 패치 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 48억 5,000만 달러에서 2026년에는 54억 1,000만 달러로, CAGR 11.4%로 성장이 전망되고 있습니다. 지난 수년간의 성장에는 선천성 심장병 발생률 증가, 심혈관 수술의 확대, 합성 수복 패치의 채택, 생체 재료 과학의 발전, 전문 심장 수술센터 증가 등이 요인으로 작용한 것으로 보입니다.

심혈관 및 연조직 수복 패치 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 80억 9,000만 달러에 달하며, CAGR은 10.6%에 달할 전망입니다. 예측 기간의 성장 요인으로는 재생의료를 응용한 심혈관 치료 수요 증가, 조직공학 연구에 대한 투자 확대, 첨단 심장 재건 수술의 보급, 흡수성 패치 재료에 대한 관심 증가, 개인 맞춤형 수리 솔루션의 채택 확대 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 생물학적 수복 패치의 채택 증가, 조직공학 소재의 활용 확대, 재생의료 응용 심장치료에 대한 집중 강화, 저침습적 패치 이식의 보급, 생체적합성 및 치유 효과에 대한 집중적인 노력 등을 들 수 있습니다.

심장 질환 관련 패치에 대한 수요 증가는 심혈관 및 연조직 복구 패치 시장의 성장을 촉진할 것으로 예측됩니다. 심장질환은 심장과 혈관과 관련된 다양한 장애를 포괄합니다. 심장질환 대응 패치에 대한 수요 증가는 흡연, 음주 등 생활습관 요인에 큰 영향을 받고 있습니다. 예를 들어 2024년 5월 조지아주에 본부를 둔 미국 질병예방통제센터(CDC)는 2022년 심장병이 70만 2,880명의 사망 원인으로 전체 사망자 5명 중 1명이 심장병으로 사망할 것이라고 보고했습니다. 이는 33초마다 1명이 심혈관 질환으로 목숨을 잃는다는 계산이 나옵니다. 미국에서는 매년 약 80만5천명이 심장마비를 앓고 있으며, 그 중 60만5천명은 첫 심장마비, 20만 명은 과거 심장마비를 경험한 적이 있는 사람들입니다. 따라서 심장 질환 관련 패치에 대한 수요 증가는 향후 수년간 심혈관 및 연조직 복구 패치 시장을 촉진할 것으로 예측됩니다.

심혈관 및 연조직 복구 패치 시장의 주요 기업은 환자의 성장에 대응하고 재수술 위험을 낮추며, 장기적이고 생체적합성이 높은 임플란트 수요를 충족시키기 위해 첨단 확장성 및 생체적합성 수술용 패치를 개발 중입니다. 이 패치는 가교 젤라틴으로 코팅된 편직 구조 안에 생체흡수성 실과 비흡수성 실을 결합하여 흡수성 부분이 분해되는 과정에서 생체 조직이 성장하여 이물질 반응과 염증을 감소시킵니다. 2023년 7월, 제인 주식회사는 출혈 방지, 조직 재생 촉진, 생리적 성장에 따른 확장 기능을 갖추고 석회화, 경화, 면역 반응의 위험 감소를 목적으로 하는 패치 'SYNFOLIUM(R)'에 대해 일본 국내 규제 당국의 승인을 취득했습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

Cardiovascular and soft tissue repair patches are artificial tissues created in the laboratory, composed of tissues grown in vitro and polymers. These patches serve the purpose of restoring damaged body tissues, providing mechanical regeneration support for injured myocardium layers, and reinstating the functional characteristics of damaged tissues for the treatment of cardiovascular diseases.

The primary raw materials used in the production of cardiovascular and soft tissue repair patches include ePTFE (expanded Polytetrafluoroethylene), biomaterial and tissue-engineered material, and other relevant raw materials. ePTFE, a material commonly used in medical devices like catheters and cardiac sutures, is composed of tetrafluoroethylene polymer units and is known for its biocompatible properties. The resulting products include synthetic patches and biological patches, with applications ranging from cardiac repair to various heart-related conditions such as atrial septal defect, ventricular septal defect, and vascular repair. The end users of cardiovascular and soft tissue repair patches encompass hospitals, ambulatory surgical centers, and specialty clinics.

Tariffs are impacting the cardiovascular and soft tissue repair patches market by increasing costs of imported biomaterials, polymers, processing equipment, and sterilization technologies. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported patch materials, while Asia-Pacific faces manufacturing cost pressures. These tariffs are increasing treatment costs and slowing adoption in some settings. However, they are also encouraging domestic biomaterial production, regional manufacturing expansion, and innovation in cost-effective tissue repair solutions.

The cardiovascular and soft tissue repair patches market research report is one of a series of new reports from The Business Research Company that provides cardiovascular and soft tissue repair patches market statistics, including cardiovascular and soft tissue repair patches industry global market size, regional shares, competitors with a cardiovascular and soft tissue repair patches market share, detailed cardiovascular and soft tissue repair patches market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular and soft tissue repair patches industry. This cardiovascular and soft tissue repair patches market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiovascular and soft tissue repair patches market size has grown rapidly in recent years. It will grow from $4.85 billion in 2025 to $5.41 billion in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increasing incidence of congenital heart defects, expansion of cardiovascular surgical procedures, adoption of synthetic repair patches, advancements in biomaterial science, growing availability of specialized cardiac surgery centers.

The cardiovascular and soft tissue repair patches market size is expected to see rapid growth in the next few years. It will grow to $8.09 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing demand for regenerative cardiovascular treatments, rising investments in tissue engineering research, expansion of advanced cardiac reconstruction procedures, growing focus on absorbable patch materials, increasing adoption of personalized repair solutions. Major trends in the forecast period include increasing adoption of biologic repair patches, rising use of tissue-engineered materials, growing focus on regenerative cardiac therapies, expansion of minimally invasive patch implantation, enhanced emphasis on biocompatibility and healing.

The increasing demand for patches related to cardiac disease is projected to drive the growth of the cardiovascular and soft tissue repair patches market. Cardiac disease encompasses a range of disorders associated with the heart and blood vessels. The rising need for patches addressing cardiac conditions is largely influenced by lifestyle factors, including smoking and alcohol consumption. For instance, in May 2024, the Centers for Disease Control and Prevention (CDC), a national public health agency based in Georgia, reported that in 2022, heart disease led to 702,880 deaths, accounting for 1 in every 5 fatalities. This equates to one individual succumbing to cardiovascular disease every 33 seconds. Each year, about 805,000 people in the United States suffer a heart attack, of which 605,000 are experiencing their first heart attack, while 200,000 have had a previous heart attack. Thus, the increasing demand for patches related to cardiac disease is expected to drive the cardiovascular and soft tissue repair patches market in the coming years.

Major players in the cardiovascular and soft tissue repair patches market are developing advanced expandable, bio-integrative surgical patches to meet demand for long-term, biocompatible implants that accommodate patient growth and reduce re-interventions. These patches combine bio-absorbable and non-absorbable yarns within a knitted structure coated with cross-linked gelatin; the absorbable portion degrades while native tissue grows in, lowering foreign-body response and inflammation. In July 2023, Teijin Limited received regulatory approval in Japan for SYNFOLIUM(R), a patch designed to prevent blood leakage, promote tissue regeneration, and expand with physiological growth, reducing risks of calcification, stiffening, and immune reactions.

In June 2024, Stryker, a US-based manufacturer of medical equipment, acquired Artelon for an undisclosed sum. This acquisition is intended to expand its product portfolio in joint preservation and soft tissue reconstruction. Artelon focuses on developing innovative biomaterials for soft tissue reinforcement and repair, especially in the areas of sports medicine and extremities procedures. Artelon is based in Georgia and specializes in medical equipment manufacturing.

Major companies operating in the cardiovascular and soft tissue repair patches market are B. Braun, Baxter International Inc., CorMatrix Cardiovascular Inc., CryoLife Inc., Edwards Lifesciences Corporation, LeMaitre Vascular Inc., Anteris Technologies Limited, Abbott Laboratories, Terumo Medical Corporation, Integra LifeSciences Corporation, W. L. Gore & Associates Inc., Medtronic Inc., LifeCell Corporation, ACell Inc., Tissue Regenix Group Plc, Aroa Biosurgery Ltd., LifeNet Health Inc., Cook Medical, Getinge AB, Glycar SA Pty Ltd., Biointegral Surgical Inc., Admedus Ltd., Johnson & Johnson, Stryker Corporation, Zimmer Biomet, Smith & Nephew plc, Organogenesis Inc.

North America was the largest region in the cardiovascular and soft tissue repair patches market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular and soft tissue repair patches market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiovascular and soft tissue repair patches market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiovascular and soft tissue repair patches market consists of sales of xenogeneic patch and allogeneic patch. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiovascular And Soft Tissue Repair Patches Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cardiovascular and soft tissue repair patches market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cardiovascular and soft tissue repair patches ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiovascular and soft tissue repair patches market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Cardiovascular And Soft Tissue Repair Patches Market Characteristics

3. Cardiovascular And Soft Tissue Repair Patches Market Supply Chain Analysis

4. Global Cardiovascular And Soft Tissue Repair Patches Market Trends And Strategies

5. Cardiovascular And Soft Tissue Repair Patches Market Analysis Of End Use Industries

6. Cardiovascular And Soft Tissue Repair Patches Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cardiovascular And Soft Tissue Repair Patches Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Cardiovascular And Soft Tissue Repair Patches Total Addressable Market (TAM) Analysis for the Market

9. Cardiovascular And Soft Tissue Repair Patches Market Segmentation

10. Cardiovascular And Soft Tissue Repair Patches Market Regional And Country Analysis

11. Asia-Pacific Cardiovascular And Soft Tissue Repair Patches Market

12. China Cardiovascular And Soft Tissue Repair Patches Market

13. India Cardiovascular And Soft Tissue Repair Patches Market

14. Japan Cardiovascular And Soft Tissue Repair Patches Market

15. Australia Cardiovascular And Soft Tissue Repair Patches Market

16. Indonesia Cardiovascular And Soft Tissue Repair Patches Market

17. South Korea Cardiovascular And Soft Tissue Repair Patches Market

18. Taiwan Cardiovascular And Soft Tissue Repair Patches Market

19. South East Asia Cardiovascular And Soft Tissue Repair Patches Market

20. Western Europe Cardiovascular And Soft Tissue Repair Patches Market

21. UK Cardiovascular And Soft Tissue Repair Patches Market

22. Germany Cardiovascular And Soft Tissue Repair Patches Market

23. France Cardiovascular And Soft Tissue Repair Patches Market

24. Italy Cardiovascular And Soft Tissue Repair Patches Market

25. Spain Cardiovascular And Soft Tissue Repair Patches Market

26. Eastern Europe Cardiovascular And Soft Tissue Repair Patches Market

27. Russia Cardiovascular And Soft Tissue Repair Patches Market

28. North America Cardiovascular And Soft Tissue Repair Patches Market

29. USA Cardiovascular And Soft Tissue Repair Patches Market

30. Canada Cardiovascular And Soft Tissue Repair Patches Market

31. South America Cardiovascular And Soft Tissue Repair Patches Market

32. Brazil Cardiovascular And Soft Tissue Repair Patches Market

33. Middle East Cardiovascular And Soft Tissue Repair Patches Market

34. Africa Cardiovascular And Soft Tissue Repair Patches Market

35. Cardiovascular And Soft Tissue Repair Patches Market Regulatory and Investment Landscape

36. Cardiovascular And Soft Tissue Repair Patches Market Competitive Landscape And Company Profiles

37. Cardiovascular And Soft Tissue Repair Patches Market Other Major And Innovative Companies

38. Global Cardiovascular And Soft Tissue Repair Patches Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cardiovascular And Soft Tissue Repair Patches Market

40. Cardiovascular And Soft Tissue Repair Patches Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기